BioNexus Gene Lab Corp. (BGLC) NASDAQ
2.18
-0.06(-2.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.18
-0.06(-2.68%)
Currency In USD
Address
Tower B, Vertical Business Suite
Kuala Lumpur, 59200
Malaysia
Phone
60 1 2212 6512
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
30
First IPO Date
January 08, 2021
| Name | Title | Pay | Year Born |
| Su-Leng Tan | Chief Executive Officer, President, Secretary & Director | 446,019 | 1984 |
| Set Fui Chong | Chief Financial Officer | 42,268 | 1963 |
| Too Kam Tham | Managing Director | 0 | N/A |
| Kwan Wah Chan | Marketing Manager | 0 | N/A |
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.